Skip to main content
. 2018 Jan 24;52(3):815–827. doi: 10.3892/ijo.2018.4252

Figure 4.

Figure 4

Silencing of miR-149-5p enhances the sensitivity of ovarian cancer cells to cisplatin in vivo. (A) Representative images of the tumors are shown in the xenograft model of nude mice. (B) At 7 days after the inoculation of the SK-OV-3 cells, the mice were intraperitoneal injected with 15 mg/kg cisplatin (CDDP) twice per week for 5 weeks. Tumor volumes in the indicated groups were measured from the 7th day at 3-day intervals. Data are presented as the means ± SD. (C) Tumor weights of each group. (D) The overall survival of mice in the indicated group. (E) The activities of caspase-3 and caspase-9 in the indicated tumors; *p<0.05.